ArteraAI Alternatives & Competitors

12 companies similar to ArteraAI — A leading precision medicine company, Artera develops AI-enabled tests to help p...

Viewpoint Molecular Targeting, Inc.

Targeted α-Particle Radiotherapy for Cancer

10 Grant $27.26M

Coralville, United States

Biotechnology Health Care +2

Pear Bio

Patient-centered cancer precision medicine

8 Series A $19.79M

London, United Kingdom

Biotechnology Health Care

Aniling

Accelerating Epigenomics for Precision Medicine against cancer

12 Seed

Badalona, Spain

Biotechnology Health Care +1

Cvergenx

An innovative leader in cancer molecular diagnostics, delivering personalized radiation th...

2 Seed $225.55K

Tampa, United States

Biotechnology Health Care

Track all ArteraAI competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Madison Vaccines

Developing innovative vaccines for prostate cancer patients and a test to determine their...

Venture round $15.81M

Biotechnology Health Care +1

MiraDx

Tailoring cancer treatment based on your patient’s unique response and toxicity profile.

28 Series A $4.00M

Los Angeles, United State...

Biotechnology Health Care

OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of ca...

52 Series C $35.38M

Belgium

Biotechnology Health Care

Agendia

MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s b...

209 Private Equity $176.05M

Irvine, United States

Biotechnology Health Care +1

Oncobit AG

Enabling personalized cancer care

15 Seed $2.45M

Schlieren, Switzerland

Biotechnology Health Care

Skin Analytics

AI for Skin Cancer Detection

123 Series B $25.95M

London, United Kingdom

AI Analytics +3

ViewRay, Inc.

Conquer cancer by re-envisioning radiation therapy.

76 Post-IPO Debt $462.49M

United States

Biotechnology Health Care +2

Nanospectra Biosciences, Inc.

Ultra-focal, Patient focused - Leveraging nanoshells in the first true focal therapy

4 Venture round $16.66M

Houston, United States

Biotechnology Health Care +2

About ArteraAI

ArteraAI, established in 2021, is carving out a niche within the precision medicine landscape. Rooted in the intersection of AI, Biotechnology, Health Care, and Life Sciences, the company is headquartered in the United States. The company's slogan, "A leading precision medicine company, Artera develops AI-enabled tests...

Taxonomy

Precision Medicine, AI-enabled Tests, Personalized Therapy, Cancer, Prostate Cancer, Biomarkers, Phase III Trials, Medical AI, Patient Outcomes, Treatment Personalization

Frequently Asked Questions

Companies similar to ArteraAI include Viewpoint Molecular Targeting, Inc., Pear Bio, Aniling, Cvergenx, Madison Vaccines. They work in Biotechnology and Health Care and share ArteraAI's focus on precision medicine, patient outcomes and prostate cancer.

Bounce Watch lists 12 companies that share ArteraAI's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches ArteraAI and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

ArteraAI Profile Pear Bio Alternatives Madison Vaccines Alternatives OncoDNA Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at ArteraAI on 11 Jun 2025. The 11 companies listed here were last checked between 25 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.